Release Date: 2024-06-10

Imaging in Bladder Tumors

Ilyas Dundar (Author)

Release Date: 2024-06-10

The bladder is a flexible, hollow pyramidal-shaped organ surrounded by pelvic fat located in the extraperitoneal space. The layers of the bladder wall, from the inside out, include the uroepithelium (mucosa), lamina propria (submucosa), muscularis propria, and adventitia. Mucosa consists of flexible transitional cell layers and changes shape when the bladder is stretched. Within the [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inThe Radiology of Cancer
    First Page217
    Last Page236
    DOIhttps://doi.org/10.69860/nobel.9786053359364.18
    Page Count20
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

    The bladder is a flexible, hollow pyramidal-shaped organ surrounded by pelvic fat located in the extraperitoneal space. The layers of the bladder wall, from the inside out, include the uroepithelium (mucosa), lamina propria (submucosa), muscularis propria, and adventitia. Mucosa consists of flexible transitional cell layers and changes shape when the bladder is stretched. Within the bladder, the uroepithelium is composed of layers of transitional cells, which have the potential to undergo benign or malignant tumor formation. Primary tumors most commonly (90%-95%) originate from the uroepithelium. Although these tumors are clinically and radiologically similar, the definitive diagnosis is made by biopsy. However, many of these tumors have various radiological features that can guide the clinical approach.Bladder cancer presents a multifaceted challenge, exhibiting diverse tumor behaviors and unpredictable clinical outcomes. Imaging holds significance in both staging and monitoring bladder cancer. Continuous advancements in MR imaging technology have notably enhanced bladder cancer evaluation. The adoption and implementation of vesical imaging reporting and data system are poised to enhance communication throughout the diagnostic, staging, and surveillance processes for patients with BCa. This section will cover the general clinical characteristics and more detailed radiologic findings of bladder tumors.

    Ilyas Dundar (Author)
    Associate Professor, Van Yuzuncu Yil University
    https://orcid.org/0000-0002-1429-077X
    3Associate Professor İlyas Dündar completed his primary education at Van İnönü Primary School (1996), his secondary education at Van İkinisan Secondary School (1997-2000), and his high school education at Van Milli Piyango Anatolian High School (2000-2004). In 2005, he was admitted to Istanbul University Istanbul Faculty of Medicine and received his medical degree in 2011. Between 2011 and 2013, he worked as a general practitioner in Ağrı-Patnos and Van. In 2013, he began his radiology residency at the Department of Radiology, Van Yüzüncü Yıl University Faculty of Medicine, working as a research assistant. In 2018, he became a specialist physician and started working at Bingöl State Hospital. In 2020, he transferred from Bingöl State Hospital to the Department of Radiology, Van Yüzüncü Yıl University Faculty of Medicine, as an Assistant Professor. Dr. Dündar received the title of Associate Professor in 2022 and was appointed to the Associate Professor position at Van Yüzüncü Yıl University Faculty of Medicine in 2023. He has authored many research articles, oral presentations and poster presentations throughout his research life. Dr. Dündar is a member of many professional organizations including Turkish Society of Radiology, European Society of Radiology, Turkish Magnetic Resonance Society and is currently working in the fields of Urogenital and Abdominal Radiology at Van Yüzüncü Yıl University Faculty of Medicine.

    • Dighe MK, Bhargava P, Wright J. Urinary bladder masses: Techniques, imaging spectrum, and staging. J Comput Assist Tomogr. 2011;35(4):411–24.

    • Walsh P.C RAB, Vaughan E.D, Wein A.J. Campbell’s Urology. 8th ed. Vol. 4th. Philadelphia: Saunders; 2002. 2732–2765 p.

    • Saddler T. Urogenital system. In: Langman’s Medical Embryology. 6th ed. Baltimore: Williams & Wilkins; 1990. p. 260–96.

    • Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al. Bladder cancer: Epidemiology, staging and grading, and diagnosis. Urology. 2005;66(6 SUPPL. 1):4–34.

    • Zhang J, Gerst S, Lefkowitz RA, Bach A. Imaging of Bladder Cancer. Radiol Clin North Am. 2007 Jan;45(1):183–205.

    • Zang Y, Li X, Cheng Y, Qi F, Yang N. An overview of patients with urothelial bladder cancer over the past two decades: a Surveillance, Epidemiology, and End Results (SEER) study. Ann Transl Med. 2020;8(23):1587–1587.

    • Halk Sağlığı Genel Müdürlüğü. Türkiye Kanser İstatistikleri 2018. Ankara; 2022.

    • Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;68(6):394–424.

    • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.

    • Gandhi N, Krishna S, Booth CM, Breau RH, Flood TA, Morgan SC, et al. Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis. BJU Int. 2018;122(5):744–53.

    • Sloan FA, Yashkin AP, Akushevich I, Inman BA. The Cost to Medicare of Bladder Cancer Care. Eur Urol Oncol. 2020;3(4):515–22.

    • McDougal WS, Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, et al. Campbell-Walsh Urology 10th Edition Review, 1e. Philadelphia: Elsevier Health Sciences; 2011. 704 p.

    • Murphy WM. Tumors of the kidney, bladder, and related urinary structures. AFIP atlas tumor Pathol Ser 4. 2004;328–30.

    • Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.

    • Takeuchi M, Sasaki S, Naiki T, Kawai N, Kohri K, Hara M, et al. MR imaging of urinary bladder cancer for T‐staging: A review and a pictorial essay of diffusion‐weighted imaging. J Magn Reson Imaging. 2013;38(6):1299–309.

    • Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D’Agostino D, et al. Imaging in Bladder Cancer: Present Role and Future Perspectives. Urol Int. 2010 Dec 1;85(4):373–80.

    • Panebianco V, De Berardinis E, Barchetti G, Simone G, Leonardo C, Grompone MD, et al. An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer. Eur Radiol. 2017 Sep 1;27(9):3759–66.

    • Hafeez S, Huddart R. Advances in bladder cancer imaging. BMC Med. 2013;11:1–10.

    • Wong VK, Ganeshan D, Jensen CT, Devine CE. Imaging and Management of Bladder Cancer. Cancers 2021, Vol 13, Page 1396. 2021 Mar 19;13(6):1396.

    • Li Q yang, Tang J, He E hui, Li Y mi, Zhou Y, Zhang X, et al. Clinical utility of three-dimensional contrast-enhanced ultrasound in the differentiation between noninvasive and invasive neoplasms of urinary bladder. Eur J Radiol. 2012;81(11):2936–42.

    • Trinh TW, Glazer DI, Sadow CA, Sahni VA, Geller NL, Silverman SG. Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results. Abdom Radiol. 2018 Mar 1;43(3):663–71.

    • Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, et al. Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Mar 5;18(3):329–54.

    • Vikram R, Sandler CM, Ng CS. Imaging and staging of transitional cell carcinoma: Part 1, lower urinary tract. Am J Roentgenol. 2009 Jun 23;192(6):1481–7.

    • Setty BN, Holalkere NS, Sahani D V., Uppot RN, Harisinghani M, Blake MA. State-of-the-Art Cross-Sectional Imaging in Bladder Cancer. Curr Probl Diagn Radiol. 2007 Mar 1;36(2):83–96.

    • Morgan CL, Calkins RF, Cavalcanti EJ. Computed tomography in the evaluation, staging, and therapy of carcinoma of the bladder and prostate. Radiology. 1981 Sep 1;140(3):751–61.

    • Macvicar AD. Bladder cancer staging. BJU Int. 2000 Jul 1;86(s1):111–22.

    • Girard A, Vila Reyes H, Shaish H, Grellier JF, Dercle L, Salaün PY, et al. The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma. Front Oncol. 2020;10.

    • Horn T, Zahel T, Adt N, Schmid SC, Heck MM, Thalgott MK, et al. Evaluation of Computed Tomography for Lymph Node Staging in Bladder Cancer Prior to Radical Cystectomy. Urol Int. 2016 Jan 1;96(1):51–6.

    • Saksena MA, Dahl DM, Harisinghani MG. New imaging modalities in bladder cancer. World J Urol. 2006 Nov;24(5):473–80.

    • Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol. 2004;22(21):4357–68.

    • Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol. 2018 Sep 1;74(3):294–306.

    • Cornelissen SWE, Veenboer PW, Wessels FJ, Meijer RP. Diagnostic Accuracy of Multiparametric MRI for Local Staging of Bladder Cancer: A Systematic Review and Meta-Analysis. Urology. 2020 Nov 1;145:22–9.

    • Giannarini G, Petralia G, Thoeny HC. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature. Eur Urol. 2012 Feb;61(2):326–40.

    • Padhani AR, Barentsz J, Villeirs G, Rosenkrantz AB, Margolis DJ, Turkbey B, et al. PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway. Radiology. 2019;292(2):464–74.

    • Panebianco V, Pecoraro M, Del Giudice F, Takeuchi M, Muglia VF, Messina E, et al. VI-RADS for Bladder Cancer: Current Applications and Future Developments. J Magn Reson Imaging. 2022 Jan 1;55(1):23–36.

    • Pecoraro M, Takeuchi M, Vargas HA, Muglia VF, Cipollari S, Catalano C, et al. Overview of VI-RADS in Bladder Cancer. AJR Am J Roentgenol. 2020 Jun 1;214(6):1259–68.

    • Kluth LA, Black PC, Bochner BH, Catto J, Lerner SP, Stenzl A, et al. Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. Vol. 68, European Urology. 2015. p. 238–53.

    • Bladder Cancer — Cancer Stat Facts [Internet]. [cited 2024 May 28]. Available from: https://seer.cancer.gov/statfacts/html/urinb.html

    • Allen BC, Oto A, Akin O, Alexander LF, Chong J, Froemming AT, et al. ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer. J Am Coll Radiol. 2019 Nov 1;16(11):S417–27.

    • Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics. 2006 Mar;26(2):553–80.

    • Dondalski M, White EM, Ghahremani GG, Patel SK. Carcinoma arising in urinary bladder diverticula: imaging findings in six patients. AJR Am J Roentgenol. 1993;161(4):817–20.

    • Erdem GU, Dogan M, Sakin A, Oruc Z, Yaman E, Yesil Cinkir H, et al. Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder. Oncol Res Treat. 2018 Apr 1;41(4):220–5.

    • Thali-Schwab CM, Woodward PJ, Wagner BJ. Computed tomographic appearance of urachal adenocarcinomas: review of 25 cases. Eur Radiol. 2005 Jan;15(1):79–84.

    • Cheng L, Pan CX, Yang XJ, Lopez-Beltran A, MacLennan GT, Lin H, et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer. 2004 Sep 1;101(5):957–62.

    • Parekh DJ, Jung C, O’conner J, Dutta S, Smith ER. Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas. Urology. 2002;60(1):164xii-164xiv.

    • Martin SA, Sears DL, Sebo TJ, Lohse CM, Cheville JC. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma. Am J Surg Pathol. 2002;26(3):292–300.

    • Mallampati GK, Siegelman ES. MR imaging of the bladder. Magn Reson Imaging Clin N Am. 2004 Aug;12(3):545–55.

    • Bates AW, Norton AJ, Baithun I S. Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases. J Clin Pathol. 2000;53(6):458–61.

    • Yeoman LJ, Mason MD, Olliff JFC. Non-Hodgkin’s lymphoma of the bladder--CT and MRI appearances. Clin Radiol. 1991;44(6):389–92.

    • Çitgez S, Erözenci A, Yörükoğlu K. Non-ürotelyal mesane kanserleri. Üroonkoloji Bülteni. 2007;4:9–14.

    • Sundaram CP, Rawal A, Saltzman B. Characteristics of bladder leiomyoma as noted on magnetic resonance imaging. Urology. 1998 Dec;52(6):1142–3.

    • Kudva YC, Sawka AM, Young WF. Clinical review 164: The laboratory diagnosis of adrenal pheochromocytoma: the Mayo Clinic experience. J Clin Endocrinol Metab. 2003 Oct;88(10):4533–9.

    • Crecelius SA, Bellah R. Pheochromocytoma of the bladder in an adolescent: sonographic and MR imaging findings. AJR Am J Roentgenol. 1995;165(1):101–3.

    • Jalil ND, Pattou FN, Combemale F, Chapuis Y, Henry JF, Peix JL, et al. Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE). Eur J Surg. 1998;164(1):23–8.

    • Shonnard KM, Jelinek JS, Benedikt RA, Kransdorf MJ. CT and MR of neurofibromatosis of the bladder. J Comput Assist Tomogr. 1992;16(3):433–8.

    • Wilkinson LM, Manson D, Smith CR. Best cases from the AFIP: plexiform neurofibroma of the bladder. Radiographics. 2004;24 Suppl 1(SPEC. ISS.).21.

    onix_3.0::thothThoth ONIX 3.0
    onix_3.0::project_museProject MUSE ONIX 3.0
    onix_3.0::oapenOAPEN ONIX 3.0
    onix_3.0::jstorJSTOR ONIX 3.0
    onix_3.0::google_booksGoogle Books ONIX 3.0
    onix_3.0::overdriveOverDrive ONIX 3.0
    onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
    csv::thothThoth CSV
    json::thothThoth JSON
    kbart::oclcOCLC KBART
    bibtex::thothThoth BibTeX
    doideposit::crossrefCrossRef DOI deposit
    onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
    marc21record::thothThoth MARC 21 Record
    marc21markup::thothThoth MARC 21 Markup
    marc21xml::thothThoth MARC 21 XML

    Share This Chapter!